<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01276938</url>
  </required_header>
  <id_info>
    <org_study_id>istgeiort</org_study_id>
    <nct_id>NCT01276938</nct_id>
  </id_info>
  <brief_title>Exclusive Intraoperative Radiation Therapy for Breast Cancer</brief_title>
  <official_title>Tolerance Evaluation of Exclusive Intraoperative Radiation Therapy at Different Doses for Breast Cancer Conservative Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to evaluate toxicity in breast cancer patients treated with two different
      doses of Intra Operative Radiotherapy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early toxicity</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of early toxicity using modified RTOG scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Late toxicity</measure>
    <time_frame>5 years</time_frame>
    <description>Assessment of late toxicity using modified LENT scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cosmetic outcome</measure>
    <time_frame>5 years</time_frame>
    <description>Assessment of cosmetic outcome according to semi-objective criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Local Relapse Free Survival (LRFS)</measure>
    <time_frame>10 years</time_frame>
    <description>Local recurrence rate will be continuously monitored in order to stop the trial in case results will be consistently worse than expected according to literature data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Free Survival (DFS)</measure>
    <time_frame>10 years</time_frame>
    <description>Disease Free Survival will be continuously monitored in order to stop the trial in case results will be consistently worse than expected according to literature data</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Breast Neoplasms</condition>
  <condition>Toxicity</condition>
  <arm_group>
    <arm_group_label>IORT 21 Gy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single fraction 21 Gy Intraoperative Radiation Therapy for breast tumors with diameter between 10 and 25 mm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IORT 18 Gy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single fraction 18 Gy Intra Operative Radiation Therapy in breast tumors smaller than 10 mm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>21 Gy radiation</intervention_name>
    <description>21 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)</description>
    <arm_group_label>IORT 21 Gy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>18 Gy radiation</intervention_name>
    <description>18 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)</description>
    <arm_group_label>IORT 18 Gy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non lobular epithelial breast carcinoma, excised with standard quadrantectomy

          -  Age ≥ 45 and &lt; 85

          -  Tumor major diameter ≤ 2.5 cm

          -  Negative surgical margins (≥ 5 mm)

          -  Willingness to undergo follow up examinations

          -  Willingness to undergo imaging examinations (MRI, mammograms, ultrasonography)

          -  Signed informed consent

        Exclusion Criteria:

          -  Ductal carcinoma in situ or lobular carcinoma

          -  Extensive intraductal component (greater than 25%) or intraductal carcinoma with
             microinvasion

          -  Serious concomitant disease or any disorder or condition (such as psychiatric or
             addictive disorders) that, in the opinion of the investigator, would preclude the
             patient from meeting the study requirements

          -  Pregnancy or lactation at the time of enrolment proposal (if necessary, during the
             trial patients must use effective contraceptive device)

          -  Collagen vascular disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marina Guenzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS AOU SanMartino IST</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS AOU San Martino- IST</name>
      <address>
        <city>Genoa</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Guenzi M, Fozza A, Timon G, Belgioia L, Vidano G, Cavagnetto F, Agostinelli S, Gusinu M, Carli F, Cafiero F, Friedman D, Canavese G, Corvò R. A two-step selection of breast cancer patients candidates for exclusive IORT with electrons: a mono-institutional experience. Anticancer Res. 2012 Apr;32(4):1533-6.</citation>
    <PMID>22493397</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2011</study_first_submitted>
  <study_first_submitted_qc>January 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2011</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <name_title>Marina Guenzi, MD</name_title>
    <organization>National Institute for Cancer Research, Italy</organization>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Intra Operative Radiation Therapy</keyword>
  <keyword>Toxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

